Holdings (Monthly)
Guide ↗
Global X Genomics & Biotechnology ETF
· Global X Funds| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GUARDANT HEALTH, INC. | 40131M109 | Feb 2026 | 24,059 | -2,202 | $3.1M | +26.5% | 5.59% | EC |
| 2 | ILLUMINA, INC. | 452327109 | Feb 2026 | 16,512 | -3,461 | $2.7M | +0.2% | 4.82% | EC |
| 3 | NATERA, INC. | 632307104 | Feb 2026 | 10,370 | +527 | $2.3M | +13.1% | 4.15% | EC |
| 4 | BIOMARIN PHARMACEUTICAL INC. | 09061G101 | Feb 2026 | 39,792 | +3,194 | $2.3M | +0.9% | 4.09% | EC |
| 5 | ARROWHEAD PHARMACEUTICALS, INC. | 04280A100 | Feb 2026 | 29,150 | -17,957 | $2.3M | -23.8% | 4.07% | EC |
| 6 | Legend Biotech Corp | 52490G102 | Feb 2026 | 83,099 | +24,028 | $2.3M | +101.1% | 4.05% | EC |
| 7 | Praxis Precision Medicines Inc | 74006W207 | Feb 2026 | 6,388 | -3,309 | $2.2M | -31.5% | 4.01% | EC |
| 8 | Twist Bioscience Corp | 90184D100 | Feb 2026 | 33,087 | +7,450 | $2.2M | +83.9% | 3.97% | EC |
| 9 | VERTEX PHARMACEUTICALS INCORPORATED | 92532F100 | Feb 2026 | 4,923 | +372 | $2.2M | -2.6% | 3.95% | EC |
| 10 | CRISPR Therapeutics AG | H17182108 | Feb 2026 | 38,191 | +7,853 | $2.1M | +17.6% | 3.85% | EC |
| 11 | Veracyte Inc | 92337F107 | Feb 2026 | 43,807 | +9,595 | $2.0M | +62.2% | 3.64% | EC |
| 12 | Qiagen N.V. | N72482156 | Feb 2026 | 53,909 | +15,698 | $2.0M | +3.7% | 3.54% | EC |
| 13 | BioNTech SE | 09075V102 | Feb 2026 | 19,841 | +1,474 | $1.9M | -6.0% | 3.41% | EC |
| 14 | BIO-TECHNE CORPORATION | 09073M104 | Feb 2026 | 36,783 | +6,180 | $1.9M | +5.3% | 3.41% | EC |
| 15 | MODERNA, INC. | 60770K107 | Feb 2026 | 38,755 | -38,086 | $1.8M | -55.6% | 3.28% | EC |
| 16 | 10X Genomics Inc | 88025U109 | Feb 2026 | 63,665 | +14,541 | $1.8M | +59.1% | 3.23% | EC |
| 17 | Beam Therapeutics Inc | 07373V105 | Feb 2026 | 52,306 | +11,679 | $1.7M | +49.0% | 3.09% | EC |
| 18 | BNYREPOS | BNYREPOS | Feb 2026 | 1,700,474 | +1,201,556 | $1.7M | +123.3% | 3.05% | RA |
| 19 | ELI LILLY AND COMPANY | 532457108 | Feb 2026 | 1,169 | +4 | $1.3M | +5.4% | 2.32% | EC |
| 20 | Ultragenyx Pharmaceutical Inc | 90400D108 | Feb 2026 | 52,426 | +12,647 | $1.3M | +34.9% | 2.25% | EC |
| 21 | CARIS LIFE SCIENCES, INC. | 142152107 | May 2026 | 67,748 | NEW | $1.1M | — | 2.03% | EC |
| 22 | Genscript Biotech Corp | N/A | Feb 2026 | 638,818 | NEW | $1.1M | — | 2.00% | EC |
| 23 | BillionToOne Inc | N/A | Feb 2026 | 11,121 | NEW | $1.1M | — | 1.97% | EC |
| 24 | GILEAD SCIENCES, INC. | 375558103 | Feb 2026 | 8,107 | +98 | $1.1M | -8.6% | 1.95% | EC |
| 25 | ASTRAZENECA PLC | N/A | Feb 2026 | 5,490 | NEW | $1.0M | — | 1.83% | EC |
| 26 | SAREPTA THERAPEUTICS, INC. | 803607100 | Feb 2026 | 56,133 | +15,157 | $1.0M | +46.1% | 1.80% | EC |
| 27 | Uniqure NV | N90064101 | Feb 2026 | 31,188 | +6,946 | $890K | +134.8% | 1.59% | EC |
| 28 | INTELLIA THERAPEUTICS, INC. | 45826J105 | Feb 2026 | 63,134 | +18,065 | $888K | +43.0% | 1.59% | EC |
| 29 | Stoke Therapeutics Inc | 86150R107 | Feb 2026 | 26,232 | +21,710 | $811K | +392.5% | 1.45% | EC |
| 30 | GeneDx Holdings Corp | 81663L200 | Feb 2026 | 14,482 | +3,212 | $753K | -16.2% | 1.35% | EC |
| 31 | DANAHER CORPORATION | 235851102 | May 2026 | 3,573 | NEW | $653K | — | 1.17% | EC |
| 32 | BRISTOL-MYERS SQUIBB COMPANY | 110122108 | Feb 2026 | 11,273 | -11,005 | $645K | -53.6% | 1.16% | EC |
| 33 | Vir Biotechnology Inc | 92764N102 | Feb 2026 | 64,900 | +24,762 | $619K | +69.7% | 1.11% | EC |
| 34 | CAREDX, INC. | 14167L103 | Feb 2026 | 25,735 | +3,427 | $587K | +40.3% | 1.05% | EC |
| 35 | WAVE Life Sciences Ltd | Y95308105 | Feb 2026 | 87,259 | +30,814 | $574K | -27.0% | 1.03% | EC |
| 36 | Personalis Inc | 71535D106 | Feb 2026 | 38,475 | +14,913 | $439K | +105.5% | 0.79% | EC |
| 37 | Maravai LifeSciences Holdings Inc | 56600D107 | Feb 2026 | 58,810 | +12,136 | $282K | +69.9% | 0.51% | EC |
| 38 | BRUKER CORPORATION | 116794108 | May 2026 | 4,056 | NEW | $239K | — | 0.43% | EC |
| 39 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 69404D108 | Feb 2026 | 151,435 | +31,939 | $226K | +12.4% | 0.40% | EC |
| 40 | Benitec Biopharma Inc | 08205P209 | May 2026 | 18,350 | NEW | $212K | — | 0.38% | EC |
| 41 | AGILENT TECHNOLOGIES, INC. | 00846U101 | Feb 2026 | 1,553 | -100 | $210K | +4.9% | 0.38% | EC |
| 42 | FULGENT GENETICS, INC. | 359664109 | Feb 2026 | 11,030 | +2,267 | $200K | +48.9% | 0.36% | EC |
| 43 | STANDARD BIOTOOLS INC. | 34385P108 | Feb 2026 | 170,786 | +51,463 | $196K | +45.7% | 0.35% | EC |
| 44 | MYRIAD GENETICS, INC. | 62855J104 | Feb 2026 | 48,961 | +9,719 | $194K | +7.4% | 0.35% | EC |
| 45 | EDITAS MEDICINE, INC. | 28106W103 | Feb 2026 | 54,725 | +8,016 | $189K | +84.3% | 0.34% | EC |
| 46 | Prime Medicine, Inc | 74168J101 | Feb 2026 | 53,111 | +12,440 | $189K | +0.3% | 0.34% | EC |
| 47 | Regenxbio Inc | 75901B107 | Feb 2026 | 25,888 | +5,405 | $181K | -2.0% | 0.33% | EC |
| 48 | ROCKET PHARMACEUTICALS, INC. | 77313F106 | Feb 2026 | 57,609 | +20,042 | $177K | -6.0% | 0.32% | EC |
| 49 | MESA LABORATORIES, INC. | 59064R109 | Feb 2026 | 1,589 | -262 | $162K | -9.3% | 0.29% | EC |
| 50 | Caribou Biosciences Inc | 142038108 | Feb 2026 | 68,184 | +8,271 | $161K | +41.4% | 0.29% | EC |
| 51 | QUEST DIAGNOSTICS INCORPORATED | 74834L100 | May 2026 | 789 | NEW | $154K | — | 0.28% | EC |
| ✕ | Avidity Biosciences Inc | 05370A108 | — | 27,249 | SOLD | $2.0M | — | — | — |
| ✕ | ALNYLAM PHARMACEUTICALS, INC. | 02043Q107 | — | 3,941 | SOLD | $1.3M | — | — | — |
| ✕ | Arcturus Therapeutics Holdings Inc | 03969T109 | — | 15,040 | SOLD | $0.1M | — | — | — |
| ✕ | Sana Biotechnology Inc | 799566104 | — | 26,441 | SOLD | $0.1M | — | — | — |
| ✕ | SANGAMO THERAPEUTICS, INC. | 800677106 | — | 244,820 | SOLD | $0.1M | — | — | — |
| ✕ | Atrium Therapeutics Inc | 04965N104 | — | 2,725 | SOLD | $0.0M | — | — | — |